Lisata Therapeutics, Inc.
LSTA
$5.03
-$0.01-0.20%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 15.96M | 19.00M | 21.97M | 25.83M | 31.25M |
| Total Receivables | 700.00K | 1.20M | 1.20M | 750.00K | 1.50M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1.05M | 1.38M | 1.71M | 2.03M | 1.83M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 17.70M | 21.58M | 24.89M | 28.62M | 34.58M |
|
|
|||||
| Total Current Assets | 17.70M | 21.58M | 24.89M | 28.62M | 34.58M |
| Net Property, Plant & Equipment | 18.00K | 22.00K | 95.00K | 167.00K | 210.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | 139.00K | 157.00K | 174.00K | 192.00K |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 23.00K | 23.00K | 23.00K | 23.00K | 22.00K |
| Total Assets | 17.74M | 21.76M | 25.16M | 28.98M | 35.00M |
|
|
|||||
| Total Accounts Payable | 1.02M | 619.00K | 782.00K | 602.00K | 1.28M |
| Total Accrued Expenses | 2.05M | 3.95M | 3.48M | 3.11M | 4.19M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | 47.00K | 92.00K | 137.00K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 3.07M | 4.57M | 4.31M | 3.81M | 5.61M |
|
|
|||||
| Total Current Liabilities | 3.07M | 4.57M | 4.31M | 3.81M | 5.61M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 72.00K | 72.00K | 72.00K | 72.00K | 72.00K |
| Total Liabilities | 3.14M | 4.64M | 4.39M | 3.88M | 5.69M |
|
|
|||||
| Common Stock & APIC | 580.25M | 579.82M | 579.24M | 578.93M | 578.43M |
| Retained Earnings | -564.65M | -561.70M | -557.45M | -552.79M | -548.07M |
| Treasury Stock & Other | -745.00K | -750.00K | -758.00K | -786.00K | -789.00K |
| Total Common Equity | 14.86M | 17.37M | 21.03M | 25.36M | 29.57M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 14.86M | 17.37M | 21.03M | 25.36M | 29.57M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -254.00K | -254.00K | -254.00K | -254.00K | -254.00K |
| Total Equity | 14.60M | 17.12M | 20.78M | 25.10M | 29.32M |
|
|
|||||